Korean J Gastroenterol.  2016 Aug;68(2):123-125. 10.4166/kjg.2016.68.2.123.

Can Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-inflammatory Druginduced Small Bowel Injury?

• Jeon SR

• KMID: 2350092
• DOI: http://doi.org/10.4166/kjg.2016.68.2.123

Abstract

No abstract available.

MeSH Terms

Incidence*
Proton Pump Inhibitors*
Proton Pumps*
Protons*
Proton Pump Inhibitors
Proton Pumps
Protons

Reference

References

1. Fujimori S, Gudis K, Takahashi Y, et al. Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest. 2010; 40:504–510.

2. Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, crossover study. J Gastroenterol. 2008; 43:270–276.

3. Washio E, Esaki M, Maehata Y, et al. Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: a randomized, placebo-controlled trial. Clin Gastroenterol Hepatol. 2016; 14:809–815.e1.

4. Arakawa T, Watanabe T, Tanigawa T, et al. Small intestinal injury caused by NSAIDs/aspirin: finding new from old. Curr Med Chem. 2012; 19:77–81.

5. Rhee SH. Lipopolysaccharide: basic biochemistry, intracellular signaling, and physiological impacts in the gut. Intest Res. 2014; 12:90–95.

6. Umegaki E, Yoda Y, Tokioka S, Murano M, Higuchi K. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats. J Gastroenterol Hepatol. 2010; 25(Suppl 1):S35–S40.

7. Yoda Y, Amagase K, Kato S, et al. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin-induced small intestinal ulceration in rats through induction of heme oxygenase-1. J Physiol Pharmacol. 2010; 61:287–294.

8. Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011; 141:1314–1322. 1322.e1–5.

9. Freedberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015; 149:883–885.e9.

10. Han DS. Current status and prospects of intestinal microbiome studies. Intest Res. 2014; 12:178–83.

11. Watanabe T, Tanigawa T, Nadatani Y, et al. Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage. Dig Liver Dis. 2013; 45:390–395.

12. Goldstein JL, Eisen GM, Lewis B, et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther. 2007; 25:1211–1222.

13. Chan FK. Do proton pump inhibitors exacerbate nonsteroidal anti-inflammatory drug-induced small-bowel enteropathy? Clin Gastroenterol Hepatol. 2016; 14:816–817.

14. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010; 376:173–179.

15. Endo H, Higurashi T, Hosono K, et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol. 2011; 46:894–905.

16. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012; 488:178–184.